标题
Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients
作者
关键词
Diffuse large B cell lymphoma, Elderly, Frail, Chemotherapy, Comorbidity, Comprehensive geriatric assessment, R-CHOP
出版物
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 19, Issue 10, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-01
DOI
10.1007/s11864-018-0565-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC
- (2017) Ulrike Paul et al. LEUKEMIA & LYMPHOMA
- R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma
- (2016) Kamel Laribi et al. ANNALS OF HEMATOLOGY
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes
- (2016) Lauren R. Teras et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma
- (2016) N M Reddy et al. LEUKEMIA
- Short-course R-CHOP followed by 90Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results
- (2016) V Stefoni et al. Blood Cancer Journal
- Efficacy and Tolerability of Anthracycline-Based Therapy in Elderly Patients With Diffuse Large B-Cell Lymphoma
- (2015) Christine C. Davis et al. Clinical Lymphoma Myeloma & Leukemia
- Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study
- (2015) Grzegorz S. Nowakowski et al. JOURNAL OF CLINICAL ONCOLOGY
- R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma
- (2014) Stephan Kreher et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
- (2014) Michael Pfreundschuh et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)
- (2014) Alessandra Tucci et al. LEUKEMIA & LYMPHOMA
- Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA
- (2013) A. Trebouet et al. ANNALS OF ONCOLOGY
- Suboptimal dosing of rituximab in male and female patients with DLBCL
- (2013) M. Pfreundschuh et al. BLOOD
- De Novo Treatment of Diffuse Large B-Cell Lymphoma With Rituximab, Cyclophosphamide, Vincristine, Gemcitabine, and Prednisolone in Patients With Cardiac Comorbidity: A United Kingdom National Cancer Research Institute Trial
- (2013) Paul A. Fields et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial
- (2013) Richard Delarue et al. LANCET ONCOLOGY
- Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome
- (2013) Karin Boslooper et al. LEUKEMIA & LYMPHOMA
- Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma
- (2012) W. Klapper et al. BLOOD
- Under-Representation of Older Adults in Cancer Registration Trials: Known Problem, Little Progress
- (2012) Kevin S. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment decisions for elderly patients with haematological malignancies: a dilemma
- (2012) Frédéric Peyrade et al. LANCET ONCOLOGY
- Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
- (2011) A Smith et al. BRITISH JOURNAL OF CANCER
- The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age
- (2011) S. Mareschal et al. HAEMATOLOGICA
- Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
- (2011) Frédéric Peyrade et al. LANCET ONCOLOGY
- Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi
- (2011) Francesco Merli et al. LEUKEMIA & LYMPHOMA
- Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
- (2010) M. Aapro et al. ANNALS OF ONCOLOGY
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search